| GSK269962A |
ENSG00000125804.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000142396.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000164621.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000172250.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000174171.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000174365.15 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000177410.8 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000178977.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000179406.6 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000179523.4 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000179743.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000180769.4 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000181798.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000182376.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000185433.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000185495.6 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000186056.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000189223.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000196756.7 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000197332.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000197813.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000198221.7 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000203279.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000203721.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000203801.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000204588.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000204623.4 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000204929.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000204934.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000205559.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000206140.5 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000206195.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000212163.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000213971.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000213971.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000214184.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000214401.4 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000214725.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000214851.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000215039.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000215159.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000215769.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000215863.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000223401.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000223442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000223462.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000223478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000223522.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000223685.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000223692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000223704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000223813.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000223842.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000223882.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000223935.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000223979.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000224138.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000224281.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000224460.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000224481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000224596.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000224699.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000224799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000224812.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000224885.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000224950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000225057.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000225113.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000225210.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000225218.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000225234.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000225331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000225331.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000225335.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000225361.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000225555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000225602.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000225643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000225733.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000225751.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000225791.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000225806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000226200.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000226266.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000226266.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000226328.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000226381.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000226419.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000226562.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000226604.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000226649.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000226711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000226758.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000226853.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000226856.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000226864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000226920.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000226950.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000226957.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000227036.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000227050.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000227070.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000227192.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000227256.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000227285.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000227359.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000227409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000227477.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000227518.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000227544.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000227603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000227674.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000227680.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000227733.4 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000227848.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000227857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000227885.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000227888.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000227895.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000228028.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000228065.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000228079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000228107.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000228113.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000228124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000228192.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000228274.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000228350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000228350.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000228386.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000228386.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000228397.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000228604.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000228614.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000228624.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000228775.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000228878.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000228886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000228989.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000229036.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000229043.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000229111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000229127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000229152.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000229512.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000229582.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000229692.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000229697.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000229728.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000229862.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000229873.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000229931.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000229956.5 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000230002.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000230148.4 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000230310.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000230323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000230423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000230423.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000230454.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000230498.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000230536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000230613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000230658.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000230724.5 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000230747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000230826.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000230850.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000230896.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000230896.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000231131.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000231185.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000231305.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000231327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000231329.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000231429.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000231481.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000231486.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000231512.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000231519.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000231551.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000231721.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000231728.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000231764.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000231770.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000231830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000231889.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000232151.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000232336.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000232342.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000232377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000232377.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000232458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000232542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000232542.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000232545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000232600.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000232618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000232633.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000232684.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000232692.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000232712.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000232719.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000232860.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000232878.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000232977.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000233006.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000233008.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000233178.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000233220.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000233367.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000233396.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000233421.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000233452.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000233483.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000233613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000233785.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000233825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000233825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000233848.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000233871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000234006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000234129.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000234183.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000234184.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000234197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000234225.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000234232.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000234245.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000234263.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000234281.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000234292.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000234390.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000234393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000234393.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000234689.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000234705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000234707.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000234945.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000234978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000235079.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000235121.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000235214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000235358.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000235398.4 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000235398.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000235488.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000235527.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000235530.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000235545.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000235560.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000235795.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000235802.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000235843.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000235989.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000236021.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000236064.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000236137.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000236144.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000236308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000236308.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000236318.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000236364.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000236383.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000236432.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000236449.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000236472.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000236498.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000236519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000236545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000236618.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000236651.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000236924.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000236943.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000236977.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000237036.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000237126.4 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000237149.4 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000237181.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000237356.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000237737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000237772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000237805.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000237883.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000237883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000237943.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000238186.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000239335.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000239653.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000239653.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000240207.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000240219.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000240476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000240549.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000240567.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000240875.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000240996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000241211.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000241219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000241313.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000241313.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000242282.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000243008.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000243485.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000243485.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000243795.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000243960.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000244041.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000244041.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000244055.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000244063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000244124.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000244757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000244791.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000245105.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000245146.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000245148.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000245213.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000245498.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000245534.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000245534.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000245571.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000245573.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000245685.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000245849.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000246089.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000246090.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000246130.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000246145.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000246308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000246308.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000246422.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000246523.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000246582.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000246582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000246859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000247324.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000247624.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000247735.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000248019.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000248100.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000248152.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000248275.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000248323.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000248559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000248576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000248693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000248734.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000248734.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000248790.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000248866.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000248866.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000249042.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000249084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000249207.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000249476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000249572.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000249593.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000249635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000249650.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000249673.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000249685.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000250012.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000250129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000250133.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000250714.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000250751.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000250765.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000250900.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000250903.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000251018.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000251136.4 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000251161.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000251168.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000251381.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000251555.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000251556.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000251603.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000253167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000253282.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000253315.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000253369.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000253395.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000253404.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000253476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000253552.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000253616.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000253636.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000253647.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000253708.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000253712.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000253736.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000253848.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000253911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000253930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000253972.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000253986.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000254094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000254129.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000254267.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000254315.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000254353.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000254362.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000254389.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000254419.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000254477.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000254539.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000254610.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000254682.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000254691.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000254694.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000254694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000254814.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000254900.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000254911.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000254977.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000254985.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000255202.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000255237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000255310.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000255320.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000255455.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000255487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000255651.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000255670.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000255717.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000255857.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000255966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000255992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000256116.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000256234.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000256403.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000256443.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000256538.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000256789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000257086.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000257135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000257176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000257354.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000257410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000257410.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000257534.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000257742.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000257964.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000257964.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000258122.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000258136.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000258274.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000258285.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000258457.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000258673.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000258693.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000258811.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000258867.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000258884.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000258946.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000258999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000259001.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000259071.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000259088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000259118.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000259250.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000259294.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000259345.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000259349.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000259364.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000259366.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000259417.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000259418.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000259438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000259553.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000259553.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000259628.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000259628.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000259682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000259687.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000259687.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000259744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000259768.3 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000259865.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000259883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000259933.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000260059.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000260063.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000260093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000260095.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000260132.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000260236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000260273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000260288.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000260349.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000260367.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000260398.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000260418.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000260441.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000260470.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000260493.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000260510.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000260578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000260579.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000260583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000260635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000260735.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000260751.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000260774.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000260774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000260778.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000260793.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000260814.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000260814.2 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000260841.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000260871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000260927.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000260953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000260955.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000260978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000260992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000261005.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000261015.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000261096.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000261098.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000261140.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000261189.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000261220.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000261280.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000261293.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000261329.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000261373.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000261428.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000261474.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000261474.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000261533.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000261578.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000261582.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000261610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000261654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000261670.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000261693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000261737.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000261770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000261775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000261780.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000261872.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000261924.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000262001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000262115.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000262147.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000262165.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000262202.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000262265.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000262678.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000262678.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000262686.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000262903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000262944.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000262999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000263033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000263072.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000263182.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000263244.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000263350.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000263843.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000264078.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000264112.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000264125.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000264247.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000264339.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000264548.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000264812.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000264829.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000265008.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000265185.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000265399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000265490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000265692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000265791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000265800.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000265908.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000265943.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000265992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000266040.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000266176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000266236.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000266237.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000266411.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000266469.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000266498.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000266541.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000266654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000266900.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000266912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000266941.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000266970.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000266987.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000267003.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000267080.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000267136.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000267143.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000267192.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000267198.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000267199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000267201.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000267221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000267246.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000267248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000267278.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000267296.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000267342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000267366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000267383.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000267429.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000267449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000267481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000267606.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000267613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000267682.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000267702.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000267765.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000267858.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000267886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000267924.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000267939.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000268015.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000268230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000268266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000268316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000268333.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000268364.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000268499.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000268530.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000268543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000268605.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000268743.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000268895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000269044.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000269091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000269107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000269107.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000269386.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000269423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000269473.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000269487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000269653.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000269680.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000269892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000269901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000269910.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000269918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000269921.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000269924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000269940.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000269942.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000269958.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000269974.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000269996.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000269999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000270001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000270022.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000270039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000270048.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000270055.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000270066.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000270067.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000270091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000270095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000270103.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000270108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000270109.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000270117.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000270133.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000270159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000270159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000270177.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000270462.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000270482.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000270996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000271228.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000271344.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000271401.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000271427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000271751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000271849.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000271913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000271914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000271927.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000271948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000272003.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000272030.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000272077.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000272087.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000272087.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000272141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000272172.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000272172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000272219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000272226.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000272240.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000272275.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000272341.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000272349.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000272368.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000272375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000272425.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000272457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000272459.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000272489.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000272645.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000272663.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000272688.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000272754.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000272755.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000272777.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000272782.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000272812.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000272828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000272829.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000272885.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000272888.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000272892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000272902.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000272902.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000272954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000273001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000273001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000273002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| GSK269962A |
ENSG00000273011.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000273030.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000273066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000273075.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000273113.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000273117.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000273131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000273190.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000273232.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000273243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000273253.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000273271.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000273289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000273290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000273290.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000273297.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000273309.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| GSK269962A |
ENSG00000273344.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000273344.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000273355.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000273356.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000273375.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000273406.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| GSK269962A |
ENSG00000273424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000273432.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000273447.1 |
Predicted lncRNA |
Esophageal cancer |
|
| GSK269962A |
ENSG00000273464.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| GSK269962A |
ENSG00000273483.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| GSK269962A |
ENSG00000273487.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
